Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

<ul><li>Sales increased by 5.6% YoY to JPY175.6bn, but operating profit decreased by 87.5% YoY to JPY423mn.</li><li>Pharmaceutical Manufacturing and Sales business faced a 4.5% YoY sales decline to JPY19.6bn, with an operating loss of JPY652mn.</li><li>Sales in the pharmacist staffing and physician placement business rose 21.8% YoY to JPY6.0bn, with operating profit up 9.7% YoY.</li></ul>

Sales increased by 5.6% YoY to JPY175.6bn, but operating profit decreased by 87.5% YoY to JPY423mn.Pharmaceutical Manufacturing and Sales business faced a 4.5% YoY sales decline to JPY19.6bn, with an operating loss of JPY652mn.Sales in the pharmacist staffing and physician placement business rose 21.8% YoY to JPY6.0bn, with operating profit up 9.7% YoY.

Nihon Chouzai (3341 JP): 1H FY03/25 flash update

<ul><li>Sales reached JPY86.4bn (+5.6% YoY), operating loss was JPY236mn, recurring profit was JPY85mn, net loss was JPY140mn.</li><li>Sales were JPY76.6bn (+6.0% YoY), operating profit was JPY1.7bn (-40.5% YoY), 7 new pharmacies opened, 2 closed.</li><li>Sales were JPY9.9bn (-5.6% YoY), operating loss was JPY461mn, 492 products offered, 47.6% in-house manufactured products.</li></ul>

Sales reached JPY86.4bn (+5.6% YoY), operating loss was JPY236mn, recurring profit was JPY85mn, net loss was JPY140mn.Sales were JPY76.6bn (+6.0% YoY), operating profit was JPY1.7bn (-40.5% YoY), 7 new pharmacies opened, 2 closed.Sales were JPY9.9bn (-5.6% YoY), operating loss was JPY461mn, 492 products offered, 47.6% in-house manufactured products.

Nihon Chouzai (3341 JP): Q1 FY03/25 flash update

<ul>
<li>
<a href="https://www.smartkarma.com/entities/nihon-chouzai-co-ltd" target="_blank" data-smartkarma-citation="entities:5873:1" rel="noopener">Nihon Chouzai (3341 JP)</a> is an integrated healthcare company whose core business is the operation of dispensing pharmacies.</li>
<li>In FY03/23, Nihon Chouzai reported sales of JPY313.3bn, operating profit of JPY7.6bn, recurring profit of JPY7.7bn, and net income attributable to owners of the parent of JPY4.5bn.</li>
<li>Nihon Chouzai Co., Ltd. announced the retirement of treasury shares.</li>
</ul>



Nihon Chouzai (3341 JP) is an integrated healthcare company whose core business is the operation of dispensing pharmacies.
In FY03/23, Nihon Chouzai reported sales of JPY313.3bn, operating profit of JPY7.6bn, recurring profit of JPY7.7bn, and net income attributable to owners of the parent of JPY4.5bn.
Nihon Chouzai Co., Ltd. announced the retirement of treasury shares.


Expert on Japan Retail and Consumer Markets, JapanConsuming

Michael Causton

Expert on Japan Retail and Consumer Markets

Real Insight on Japanese Consumer Markets

JapanConsuming

JapanConsuming is a specialist research firm producing intelligence on Japanese retail and consumer markets. Founded in 2000, JapanConsuming has become the leading provider of insights on Japanese retailers and consumer trends to retailers, brands, government agencies and investors. As well as a highly regarded monthly report on the market, JapanConsuming produces in-depth reports on retail sectors, seminars on key trends and telephone consulting to investors on trends and retailers.

JapanConsuming was founded by Michael Causton and Roy Larke. 

Thematic (Sector/Industry)

<ul>
<li>Japan's drugstore sector is in the midst of consolidation through organic expansion and M&amp;A but who are the leaders and how do they compare?</li>
<li>We provide snapshot profiles on each of the key players, their current strategies and future outlook.</li>
<li>With the sector increasingly threatening the supermarket and convenience store sectors, many of these names will come to dominate Japanese retailing in the next decade.</li>
</ul>


Japan's drugstore sector is in the midst of consolidation through organic expansion and M&amp;A but who are the leaders and how do they compare?
We provide snapshot profiles on each of the key players, their current strategies and future outlook.
With the sector increasingly threatening the supermarket and convenience store sectors, many of these names will come to dominate Japanese retailing in the next decade.


<ul>
<li>The big merger between Welcia and Tsuruha is part of a wider concentration of market share in the drugstore sector as the leaders take on supermarkets and even convenience stores.</li>
<li>Japan's drugstores have morphed into multiple sub-formats, selling food and other FMCG products in ever higher ratios, creating massive pressure for other sectors. </li>
<li>The net effect is the emergence of a powerful new retail sector that is impacting all other FMCG retail formats and even lifestyle categories like cosmetics.</li>
</ul>


The big merger between Welcia and Tsuruha is part of a wider concentration of market share in the drugstore sector as the leaders take on supermarkets and even convenience stores.
Japan's drugstores have morphed into multiple sub-formats, selling food and other FMCG products in ever higher ratios, creating massive pressure for other sectors. 
The net effect is the emergence of a powerful new retail sector that is impacting all other FMCG retail formats and even lifestyle categories like cosmetics.


Japan Drugstores: More M&A as Sector Attacks Supermarkets and Conbini

Japan

NIHON CHOUZAI Co., Ltd. operates a drug store chain in Japan.  The Company manages drug prescriptions, orders, and inventories of all stores through an online system.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Nihon Chouzai (3341 JP)